StockData
Parabilis Medicines, Inc. logo

Parabilis Medicines, Inc. (PBLS) stock

PBLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$28.25−0.20 (-0.70%)

Close on Nov 17, 2026Market cap $3.49BP/E –Yield –

Parabilis Medicines cash

Cash and short-term investments held at the end of each period.

Parabilis Medicines's cash was $1.12B at Jun 30, 2026. For fiscal 2025 it was $27.71M, down 44.7% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$27.71M-44.7%
FY2024Dec 31, 2024$50.14M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.12B–
Q4 FY2025Dec 31, 2025$27.71M–
Q2 FY2025Jun 30, 2025$80.39M–
Q4 FY2024Dec 31, 2024$50.14M–

More Parabilis Medicines figures

See a number that looks wrong?